Full Text
An Economic Evaluation of Ranibizumab versus Aflibercept for the treatment of Neovascular (WET) AMD in the United Kingdom

Abstract

Authors

W.A. Malcolm L. Claxton R. Hodgson M. Taylor

Back to Volume 18, Issue 3
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×